Metopirone
NDC 68118-455, Metyrapone, capsule, gelatin coated, from ESTEVE PHARMACEUTICALS, S.A..
- Product NDC
- 68118-455
- Status
- Listed
- Labeler
- ESTEVE PHARMACEUTICALS, S.A.
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA012911
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68118-455 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METYRAPONE250 mg/1
Pharmacologic classes
Adrenal Steroid Synthesis Inhibitor [EPC]; Adrenal Steroid Synthesis Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68118-455-18 | 68118045518 | 18 CAPSULE, GELATIN COATED in 1 BOTTLE (68118-455-18) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4046b167-7a46-8f4a-e063-6394a90a147f
Use it
Look up 68118-455 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68118-455 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68118-455. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.